go back

Brexucabtagene Autoleucel (Tecartus) CAR-T Therapy

Vermont rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated October 2026.

How much does Tecartus (brexucabtagene autoleucel) cost?

$512,861

Typical physician fee. In Vermont, October 2026.

Insurers have agreed to pay about $512,861 for this service. Most negotiated rates run $512,861 to $512,861.

Few insurers publish rates for this combination, so treat this figure as a rough guide.

These are rates insurers have negotiated with providers, not the amount a patient is billed. What you owe depends on your plan's deductible and coinsurance. Based on rates published by 3 insurance carriers under federal price transparency rules.

How much rates vary

Professionalmedian $512,861 · 10th to 90th $512,861 to $549,541
$200K$500Kprofessional $512,861

Distribution of negotiated rates across all payers (price axis is log-scale). Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Professional
Modifier
None
Typical Low
$512,861.38
Median
$512,861.38
Typical High
$512,861.38
MVP Health Care
Setting
Professional
Modifier
None
Typical Low
$588,843.66
Median
$588,843.66
Typical High
$588,843.66
United
Setting
Professional
Modifier
None
Typical Low
$489,778.82
Median
$549,540.87
Typical High
$660,693.45

Where Vermont sits

The same service costs 2.0 times more in Texas than in New Jersey. Every bar is a state, most expensive first. Touch or drag across it to read any state, then open that state for its carriers and full range.

Vermont· 35th of 51

$512,861

TX $1,000,000NJ $489,779

Median negotiated rate in each state, from every insurer that publishes one. States where no insurer publishes a rate for this service are not shown.